New Jersey SR 35: Urges FDA to make naloxone available over the counter.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2022-01-31)

State: New Jersey · Session: 220 · Bill: SR 35

Subjects: DRUG ABUSE, PHARMACEUTIC

Sponsors: Gopal, Vin, Vitale, Joseph F.

View New Jersey SR 35 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.